All articles by Manish Kumar
Manish Kumar
Daxor expands to three new facilities as blood volume analysis technology gains momentum nationwide
Daxor’s ezBVA Lab Service Spearheads Growth and Broader Market Adoption
Oxford Nanopore joins Singapore’s NPM initiative to study multi-ethnic genetics
Oxford Nanopore will sequence 10,000 genomes from Singapore’s population within the PRECISE-SG100K cohort to improve understanding of genetic architecture and diversity
CVRx announces increased inpatient payment for Barostim procedure
Barostim System is the first medical technology approved by FDA that uses neuromodulation to improve the symptoms of heart failure
Health tech firm R1 RCM to go private in $9bn deal with TowerBrook, CD&R
R1 RCM offers services for billing and revenue collection that enhance financial performance and patient experience for health systems, hospitals, and physician groups.
Tempus AI to use new algorithms to close care gaps in IHC testing
Under the initial stage, Tempus has created an algorithm within xR, its RNA sequencing assay, to identify patients who are most likely to benefit from recommended IHC testing
BlueSleep announces care partnership with Elektra Health
New collaboration provides fast and affordable access to sleep medicine and menopausal care for women
Bracco Imaging and BURL Concepts partner to advance stroke care
Under the agreement, Bracco Imaging will manufacture a specialised microbubble solution to complement BURL Concepts’ SONAS device
AVITA Medical and Regenity to develop dermal matrix for wound care
Under the agreement, Regenity will produce the dermal matrix and AVITA Medical will have exclusive rights to market, sell, and distribute the product in the US, EU, Australia, and Japan
IMS Shin-Matsudo Central General Hospital completes first patient treatment with the ZAP-X Gyroscopic radiosurgery platform
Installation Marks the Third ZAP-X System in Japan to Offer the Latest Advance in Non-Surgical Brain Tumor Care
Thermo Fisher unveils One Lambda pre-transplant risk assessment assay
One Lambda evaluates the risk of early acute rejection in kidney transplant recipients and helps develop a more personalised strategy for managing post-transplant immunosuppression